Are you Dr. Ross?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 126 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161- Is this information wrong?
Summary
- Dr. Merrick Ross, MD is a general surgeon in Houston, Texas. He is currently licensed to practice medicine in Texas, Arizona, and Alabama. He is affiliated with University of Texas M.D. Anderson Cancer Center and is a Professor of Surgery at University Tex Houston.
Education & Training
- University of Texas Health Science Center at HoustonResidency, Surgery, 1987 - 1989
- University of Illinois College of Medicine at ChicagoResidency, Surgery, 1984 - 1987
- Scripps Clinic/Scripps Green HospitalFellowship, Allergy and Immunology, 1982 - 1983
- University of Illinois College of Medicine at ChicagoResidency, Surgery, 1980 - 1982
- University of Illinois College of MedicineClass of 1980
Certifications & Licensure
- FL State Medical License 2021 - Present
- AZ State Medical License 2023 - 2025
- TX State Medical License 1988 - 2025
- WA State Medical License 2023 - 2025
- AL State Medical License 2023 - 2024
- MS State Medical License 2023 - 2024
- TN State Medical License 2023 - 2024
- American Board of Surgery Surgery
- Join now to see all
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- Top Doctors:SE Texas Castle Connolly, 2013
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Clinical Trials
Publications & Presentations
PubMed
- Vascular stenting of a malignant arterial blowout as a bridge to effective systemic and regional therapy.Mitchell W Cox, Celyne B Hume, Taylor P Williams, Bagi Jana, Merrick I Ross, Sarah B Fisher, John P Walker, Lauren L Mayo, Douglas S Tyler> ;Journal of Surgical Oncology. 2024 Mar 27
- Multipeptide vaccines for melanoma in the adjuvant setting: long-term survival outcomes and post-hoc analysis of a randomized phase II trial.Emily K Ninmer, Hong Zhu, Kimberly A Chianese-Bullock, Margaret von Mehren, Naomi B Haas, Craig L Slingluff Jr, Merrick I Ross, Lynn T Dengel> ;Nature Communications. 2024 Mar 22
- Spitz melanocytic neoplasms with MLPH::ALK fusions: Report of two cases with previously unreported features and literature review.Haneen T Salah, Richard K Yang, Sinchita Roy-Chowdhuri, Merrick I Ross, Phyu P Aung, Aimi T Rothrock, Carlos A Torres-Cabala, Jonathan L Curry, Victor G Prieto, Priyad...> ;Journal of Cutaneous Pathology. 2024 Mar 5
- Join now to see all
Press Mentions
- Non-Hodgkin Lymphoma Caregiver: MD Anderson Saved Me and My HusbandJuly 28th, 2020
- How a Melanoma Immunotherapy Clinical Trial Helped MeNovember 28th, 2016
- Collaborative Care ChallengesSeptember 18th, 2015
Professional Memberships
- Member
Hospital Affiliations
- University of Texas M.D. Anderson Cancer CenterHouston, Texas